Human IL-4 muteins in combination with chemotherapeutics or proapoptotic agents in cancer therapy

Details for Australian Patent Application No. 2007271349 (hide)

Owner Apogenix GmbH

Inventors Gamer, Jurgen; Hoger, Thomas

Agent Davies Collison Cave

Pub. Number AU-A-2007271349

PCT Pub. Number WO2008/003514

Priority 06026609.5 21.12.06 EP; 06014080.3 06.07.06 EP

Filing date 6 July 2007

Wipo publication date 10 January 2008

International Classifications

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2008/003514 Priority application(s): WO2008/003514

27 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007271350-Small Streptococcus pyogenes antigens and their use

2007271340-Method and device for metal purification and separation of purified metal from a metal mother liquid such as aluminium